PIXITMEDIA
17.11.2022 17:41:35 CET | Business Wire | Press release
Leading software-defined storage and data management solution provider, pixitmedia, a Kalray company, and Lenovo, the Fortune Global 500 technology powerhouse, are now offering a cost-effective and ultra-scalable cloud-enabled hyper-converged solution to the Media and Entertainment industry. Hyper-converged, or HCI, unites pixitmedia’s award-winning software, pixstor™ with ngenea®, with Lenovo’s smart solutions into a single appliance, with guaranteed performance suitable for a multitude of Media and Entertainment workflows.
Historically, studios have depended on storage products supplied by major data appliance vendors. Most vendors are either yet to evolve cloud-based solutions or offer very limited cloud capabilities. This is restrictive and limits the flexibility of media creation companies as their businesses grow and content delivery models change. Having a hyper-converged infrastructure gives studios the freedom to choose where to grow their capabilities, whether it be on-premise or in the cloud. Those working remotely should have the same experience as those who choose to work on-premises and vice versa. For companies operating virtual workstations, this is a vital part of the workflow, and it is where dynamic data management can bring huge benefits. A hyper-converged approach allows creative media businesses to stay agile and keep infrastructure costs low by virtualising key elements of conventional “hardware-defined” systems.
“pixitmedia and Lenovo liberate Media and Entertainment businesses from being locked into restrictive data environments. Studios that are able to quickly adjust infrastructure, keep up with productivity and meet content demands, are able to stay competitive. A hyper-converged approach enables creative media businesses of any size to stay agile and keep infrastructure costs lower" explains Ben Leaver, EVP of Business Development, pixitmedia.
“The Media and Entertainment sector is a complex and exciting industry and Lenovo is committed to working with partners to create solutions which offer customers value. In collaboration with pixitmedia we’ve developed a solution which makes it easy for companies in this sector to deploy a hyper-converged environment.” says Ian Jeffs, UK and Ireland General Manager, Lenovo Infrastructure Solutions Group.
The collaboration between pixitmedia and Lenovo has resulted in a Hyperconverged solution that guarantees customers complete control of their data. All users can see and access the same data securely, enabling rock-solid collaboration between multiple creative sites. The solution enables businesses a simplistic transition to cloud and hybrid ways of working with no disruption to existing workflows and no compromise on security, whilst delivering guaranteed ultra-fast performance. For ultimate flexibility, the pixitmedia HCI solution works with any cloud provider over a multitude of production workflows, giving the customer the flexibility to scale up or down according to projects. pixitmedia, a global leader in cloud-workflow solutions for Media and Entertainment, has already deployed multiple hybrid solutions to over 20 global media production and distribution companies.
The solution works seamlessly across multiple operating systems and leverages cloud providers’ networks for ultra-high-speed data transfers, businesses can easily expand on-premises pipelines into the cloud with a software-defined solution such as pixstor™, while still enjoying the guaranteed sustained collaboration, performance, scalability and intelligent management tools of an on-premises deployment. Supported by ngenea®, an intelligent data transport mechanism, business experiences can be tightly integrated on-premises, and cloud infrastructure integrated under a single namespace.
By adopting integrated cloud solutions such as ngenea® and pixstor™, media creation businesses will have everything that they need, from on-premises to remote working and everything in between. pixitmedia also offers an upgrade path for the HCI solution to scale-out NAS as your business grows to give customers that added flexibility for the future.
Working together with Lenovo is about driving business forward and empowering customer workflows. Hyper-converged infrastructure offers scalability and agility, optimised performance and collaboration and the option to reduce costs. In simple terms, it gives media enterprises more choices, more collaborative efficiencies and more freedom than ever before.
For more information on pixitmedia and Lenovo HCI solutions please visit: pixitmedia.com/lenovo/
ABOUT LENOVO
Lenovo (HKSE: 992) (ADR: LNVGY) is a US$70 billion revenue global technology powerhouse, ranked #171 in the Fortune Global 500, employing 75,000 people around the world, and serving millions of customers every day in 180 markets. Focused on a bold vision to deliver smarter technology for all, Lenovo has built on its success as the world’s leading PC player by expanding into new growth areas of infrastructure, mobile, solutions and services. This transformation together with Lenovo’s world-changing innovation is building a more inclusive, trustworthy, and sustainable digital society for everyone, everywhere.
ABOUT PIXITMEDIA
pixitmedia is a Kalray company (Euronext Growth Paris: ALKAL), a leading provider of hardware and software technologies and solutions for high-performance, data-centric computing markets, from cloud to edge. pixitmedia and Kalray share a common vision and a complementary value proposition in both software and hardware to address today’s and tomorrow’s data-intensive world with solutions for a more intelligent, effective, energy-wise and user-friendly data-driven world.
pixitmedia’s award-winning purpose-built, software-defined storage and data solutions simplify the flow of data to connect an increasingly complex world. We devise optimized solutions that give customers both choice and freedom, our restless innovation constantly pushes boundaries and the unrivalled care and knowledge of our team ensure optimum performance and value. Customer success is at the heart of our business, we have technical specialists and a unique, dedicated lab facility to guarantee the effectiveness of our solutions. For more information, please visit https://pixitmedia.com or contact us: marketing@pixitmedia.com.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20221117005654/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Barilla Opens Global Call for Startups Through Good Food Makers 202625.5.2026 11:47:00 CEST | Press release
The program has involved over 1,100 startups across 50+ countries, delivering 26 pilot projects. Barilla Group has opened applications for the 2026 edition of Good Food Makers, its global open innovation program designed to co-develop and test new innovative solutions with startups and innovators inside real industrial environments. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260521973445/en/ Since its launch in 2019, the program has involved more than 1,100 startups from over 50 countries, leading to 26 pilot projects, with over 20 projects currently active thanks to the solutions developed by the program’s alumni. This highlights the program’s role as a concrete platform for industrial scalable innovation. The 2026 edition comes at a pivotal moment for the company, following the launch of BITE (Barilla Innovation & Technology Experience), the new innovation center dedicated to developing the next generation of food prod
JEOL: Sales Launch of the Laser SEM System “LazEdge”25.5.2026 10:16:00 CEST | Press release
JEOL Ltd. (President & CEO: Izumi Oi) has developed the “LazEdge”, an SEM system equipped with a laser processing system, and begins sales on May 25, 2026. Cross-section preparation instruments such as the focused ion beam system (FIB system), are widely used in science and technology fields across research institutes, universities, and industries. In recent years, demand is increasing for a system that can process large-areas at a high speed, while achieving high-quality of the processed surface. “LazEdge” is an instrument integrating JEOL’s SEM with the laser technology proprietary of Hamamatsu Photonics K.K., and enables laser processing inside the specimen chamber of the electron microscope. This system enables high-quality cross-section specimens produced through high-speed, large-area processing to be transferred seamlessly to subsequent analyses, such as SEM observation, elemental analysis, and crystal orientation analysis, without exposure to the external environment. As a resu
TFG-001, A Novel 3D Neural Microtissue Cell Therapy, Demonstrates Superior Functionality and Reinnervation for Parkinson’s Disease25.5.2026 08:00:00 CEST | Press release
TreeFrog Therapeutics, a regenerative medicine biotech company developing next-generation cell therapies, today announced that it will present new preclinical data on TFG-001 at the 7th World Parkinson’s Conference. TFG-001, a 3D neural microtissue cell therapy, demonstrated rapid dopamine release and extensive graft-derived reinnervation across multiple advanced translational Parkinson’s disease models—supporting its potential as a best-in-class candidate. The critical need for reinnervation in Parkinson's disease In Parkinson's disease, an estimated 60–80% of dopaminergic neurons are already lost before motor symptoms even appear. The nigrostriatal pathway degenerates, destroying the essential wiring that connects dopamine-producing neurons to movement control. While chemical dopamine replacements (like levodopa) can manage symptoms, they cannot restore the spatial precision, feedback loops, or dynamic regulation of a healthy brain network. To achieve true functional restoration, it
Galderma Receives U.S. FDA Approval for Differin® Epiduo® Acne Gel Prescription-to-OTC Switch22.5.2026 18:25:00 CEST | Press release
A unique Prescription-to-OTC switch in acne care, this approval expands access to a dermatologist-trusted, prescription-strength treatment for millions of acne sufferers ages 12 years and older Backed by more than 15 years of real-world dermatologist use and a robust clinical research program, this milestone demonstrates the depth of science behind the Differin® and Epiduo® heritage Adapalene plus benzoyl peroxide (0.1/2.5%) was the first FDA-approved, stable, fixed- dose prescription acne treatment to combine of benzoyl peroxide with a retinoid, and is now available over-the-counter The formulation is engineered to target multiple causes of acne more effectively than either of its individual active ingredients alone Galderma (SIX: GALD), the pure-play dermatology category leader, today announced that the United States (U.S.) Food and Drug Administration (FDA) has approved Differin® Epiduo® Acne Gel (Adapalene 0.1% and Benzoyl Peroxide 2.5% Acne Treatment) for over-the-counter (OTC) us
Avanzanite Bioscience’s Partner Agios Announces PYRUKYND® (mitapivat) Approval in the European Union for Adults with Thalassaemia22.5.2026 16:18:00 CEST | Press release
Avanzanite will commercialise and distribute PYRUKYND in Europe under its exclusive agreement with Agios Avanzanite is committed to collaborating with local authorities in the EU to enable access to PYRUKYND for adult patients with thalassaemia Avanzanite Bioscience B.V., a rapidly growing commercial-stage European specialty pharmaceutical company focused on rare diseases, today reported that its partner, Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a commercial-stage biopharmaceutical company headquartered in Cambridge, Massachusetts focused on delivering innovative medicines for patients with rare diseases, announced that the European Commission has granted marketing authorisation for PYRUKYND® (mitapivat), an oral pyruvate kinase (PK) activator, in adults for the treatment of anaemia associated with transfusion-dependent and non-transfusion-dependent alpha- or beta-thalassaemia, with an orphan medicinal product designation. This press release features multimedia. View the full releas
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom